Fernando Antoñanzas

Fernando Antoñanzas

Auto-generated profile, based on publicly available information

Fernando Antoñanzas

University of La Rioja, Logroño, Spain

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Gaceta Sanitaria
Verified
Journal Article
Open access
JBJulio López Bastida
Julio López Bastida
JOJuan Oliva-Moreno
Juan Oliva-Moreno
FAFernando Antoñanzas
Fernando Antoñanzas
AGAnna García-Altés
Anna García-Altés
RGRamón Gisbert
Ramón Gisbert
JPJaume Puig-Junoy
Jaume Puig-Junoy
Over the last few years, economic evaluation of health technologies has become a major tool used by European health policy decision-makers to create strategies for prioritizing the allocation of health resources and the approval of new technologies. Spain was a pioneer in proposing the standardization of methodology applicable to economic evaluation studies. However, because health policy decision-makers refused to support the initiative, the methodology was never put into practice. In the medium term, evidence of the economic value of new health technologies financed by the national health system will probably be increasingly required. At that time, stakeholders and decision-makers will have to agree upon a clear and concise set of rules on the technical and methodological issues that must be followed by economic evaluations of health technologies. Consequently, we have provided guidelines and recommendations for producing first-rate economic evaluations. The recommendations appear under seventeen headings or sections. In each case, the recommended requirements to be satisfied by an economic evaluation of health technologies are provided and each recommendation is followed by a commentary, providing a justification and comparing and contrasting the proposal with other available alternatives.

20 April 2010 in The European Journal of Health Economics
Verified
Journal Article
Closed access
PDF file
JLJulio López-Bastida
Julio López-Bastida
JOJuan Oliva-Moreno
Juan Oliva-Moreno
FAFernando Antoñanzas
Fernando Antoñanzas
AGAnna García-Altés
Anna García-Altés
RGRamón Gisbert
Ramón Gisbert
JPJaume Puig-Junoy
Jaume Puig-Junoy

2 December 2014 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
FAFernando Antonanzas
Fernando Antonanzas
CLCarmen Lozano
Carmen Lozano
Carmen TorresCarmen Torres
Carmen Torres

1 January 2002 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
PBPhilippe Beutels
Philippe Beutels
WEW. John Edmunds
W. John Edmunds
FAFernando Antoñanzas
Fernando Antoñanzas
GWG. Ardine De Wit
G. Ardine De Wit
DEDavid Evans
David Evans
BHBen A. van Hout
Ben A. van Hout

1 September 1995 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
JRJoan Rovira
Joan Rovira
FAFernando Antoñanzas
Fernando Antoñanzas

18 September 2019 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
FAFernando Antonanzas
Fernando Antonanzas
Carmelo A. Juárez-CastellóCarmelo A. Juárez-Castelló
Carmelo A. Juárez-Castelló
RLReyes Lorente
Reyes Lorente
RRRoberto Rodríguez-Ibeas
Roberto Rodríguez-Ibeas